Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
19.22
+0.22 (1.16%)
Feb 21, 2025, 4:00 PM EST - Market closed
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $215.67 million as of February 21, 2025.
Market Cap
215.67M
Enterprise Value
225.54M
1-Year Change
n/a
Ranking
Category
Stock Price
$19.22
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $215.67M, an increase of 49.81%. That is a compound annual growth rate of 834.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 213.20M | 58.33% |
| Dec 31, 2024 | 134.66M | -6.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |